supp.fit

Vitamin E, Vitamin B12, Vitamin B6 and Folic Acid: study protocols

9 study groups took Vitamin E together with Vitamin B12, Vitamin B6 and Folic Acid. These are the doses the studies gave. They are not a recommendation.

Vitamin E: what the research found →

Dose per serving from research: Vitamin E

8 study groups in 6 studies say how much Vitamin E participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 25 mg to 50 mg, 38% of 8 study groups.

Daily doseStudy groups
5 mg or less
1
5 mg to 10 mg
1
10 mg to 25 mg
1
25 mg to 50 mg
3
50 mg to 100 mg
1
100 mg to 250 mg
0
over 250 mg
1

Dose per serving from research: Vitamin B12

9 study groups in 7 studies say how much Vitamin B12 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 2.5 mcg to 5 mcg, 56% of 9 study groups.

Daily doseStudy groups
1 mcg or less
1
1 mcg to 2.5 mcg
1
2.5 mcg to 5 mcg
5
5 mcg to 10 mcg
0
10 mcg to 25 mcg
0
25 mcg to 50 mcg
0
50 mcg to 100 mcg
0
100 mcg to 250 mcg
0
250 mcg to 500 mcg
1
500 mcg to 1 mg
1

Dose per serving from research: Vitamin B6

9 study groups in 7 studies say how much Vitamin B6 participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 1 mg to 2.5 mg, 33% of 9 study groups.

Daily doseStudy groups
500 mcg or less
1
500 mcg to 1 mg
2
1 mg to 2.5 mg
3
2.5 mg to 5 mg
1
5 mg to 10 mg
0
10 mg to 25 mg
0
25 mg to 50 mg
1
50 mg to 100 mg
1

Dose per serving from research: Folic Acid

9 study groups in 7 studies say how much Folic Acid participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mcg to 500 mcg, 44% of 9 study groups.

Daily doseStudy groups
100 mcg to 250 mcg
2
250 mcg to 500 mcg
4
500 mcg to 1 mg
1
1 mg to 2.5 mg
0
2.5 mg to 5 mg
2

Commonly used together

8 of 9 study groups took Vitamin E, Vitamin B12, Vitamin B6 and Folic Acid with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Vitamin C
8
Zinc
5
Selenium
4
Vitamin D
4
Copper
3
Iron
3
Vitamin A
3

9 study groups

Study
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Multiple micronutrients · Pregnant women in rural Nepal
10 mg2.6 mcg2.2 mg400 mcg——
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
2015 · Active group (RCT1, RCT2 and RCT3) · Men and women aged 50 years or older with mild or mild-to-moderate Alzheimer's disease; RCT3 participants were on stable approved Alzheimer's medication, while RCT1 and RCT2 participants were drug-free for Alzheimer's medication.
40 mg3 mcg1 mg400 mcg24 weeks501
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease
2015 · Active product during open-label extension (OLE) · Men and women aged 50 years or older with mild Alzheimer's disease who completed RCT2.
40 mg3 mcg1 mg400 mcg24 weeks201
Newborn micronutrient status biomarkers in a cluster-randomized trial of antenatal multiple micronutrient compared with iron folic acid supplementation in rural Bangladesh
2020 · MM · Pregnant women in rural Bangladesh; age range not specified; no disease condition specified
15 mg2.6 mcg1.9 mg600 mcg—176
Multiple Micronutrient Powder Reduces Vitamin E Deficiency in Brazilian Children: A Pragmatic, Controlled Clinical Trial
2019 · intervention group · Children aged 6–9 months at the start of the study, male or female, attending primary health care centers in Goiânia, Brazil
5 mg0.9 mcg500 mcg150 mcg90 days107
Antioxidant supplementation with or without B-group vitamins after acute ischemic stroke: a randomized controlled trial
2006 · Antioxidant vitamins plus B-group vitamins · Acute ischemic stroke patients treated within 12 hours of symptom onset
800 IU400 mcg50 mg5 mg2 weeks24
Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD
2009 · Treatment group · Adults with stage 2 to 4 chronic kidney disease and creatinine clearance of 15 to 70 mL/min/1.73 m²
300 mg1 mg100 mg5 mg2 years47
Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study
2022 · TG1 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions
45 mg2.5 mcg2.1 mg200 mcg12 weeks30
Use of Nutraceuticals in Elderly to Fight Inflammation and Immuno-Senescence: A Randomized Case-Control Study
2022 · TG2 · Hospitalized adults older than 65 years; sex not restricted; recruited for causes other than cancer, with specified immune-disease and infection exclusions
90 mg5 mcg4.2 mg400 mcg6 weeks30